1. Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis 
Celalettin Ustun, Jason Gotlib, Uday Popat, Andrew Artz, Mark Litzow, Andreas Reiter, Ryotaro Nakamura, Hanneke C. Kluin-Nelemans, Srdan Verstovsek, James Gajewski, Miguel-Angel Perales, Tracy George, Tsiporah Shore, Wolfgang Sperr, Wael Saber, Vamsi Kota, Akif Selim Yavuz, Vinod Pullarkat, John Rogosheske, William Hogan, Koen Van Besien, Hans Hagglund, Gandhi Damaj, Michel Arock, Hans-Peter Horny, Dean D. Metcalfe, H. Joachim Deeg, Steven Devine, Daniel Weisdorf, Cem Akin, Peter Valent 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 8, Pages (August 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Variants of SM. MML indicates myelomastocytic leukemia.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Proposed algorithm for AlloHCT in patients with advanced SM. aMCL indicates acute mast cell leukemia; cMCL, chronic mast cell leukemia.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 2
Proposed algorithm for AlloHCT in patients with advanced SM. aMCL indicates acute mast cell leukemia; cMCL, chronic mast cell leukemia.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 3
An example study as a model of combining midostaurin and alloHCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions